Q3 FY2024 Earnings
Financial report interval: 2024.06.30 - 2024.09.30
Overview: Omega Therapeutics(OMGA) the Revenue is 2.612 M (+214.3%);the EBIT is -16.42 M (+28.31%);the EPS is -0.298 (+26.11%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B214.32%
----
----
EBIT
-0.02B28.31%
----
----
EPS
-0.298126.11%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf